AxoGen provides surgeons with solutions to repair and protect peripheral nerves.Read more
AxoGen's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 291.1M. Over the last four quarters, AxoGen's revenue has grown by $152K. Specifically, in Q2 2021's revenue was $33.6M; in Q1 2021, it was $31M; in Q4 2020, it was $32.5M; in Q3 2020, AxoGen's revenue was $33.4M.